- Obtains Exclusive Rights Outside Greater China For Three Pre-IND In Vivo CAR-T Programmes
- Starna To Receive Upfront Payment Of $330M
- Starna Eligible For Up To $2.30B In Milestone Payments Plus Royalties
- Holds Options To Expand Territory To Include Greater China
News / Headline
Pfizer: Enters Exclusive Licensing Agreement With Starna Therapeutics For Autoimmune Diseases
UTC